A Novel Treatment and Other Parkinson's Updates From AAN 2022 - Medscape

Dr Kathrin LaFaver and Dr Indu Subramanian discuss promising data with the GLP-1 agonist liraglutide, and other research on Parkinson's disease that caught their attention.

This transcript has been edited for clarity. Kathrin LaFaver, MD: Welcome back, everyone. This is part two of our highlights from the American Academy of Neurology annual meeting abstracts in the mo… [+11265 chars]

full article...